1176014

CorneaGen, LLC — FEI 3009122697

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
South San Francisco, CA (United States)

Citations

IDCFRDescription
1236321 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
1239821 CFR 1271.230(a)Validation & approval--established procedures